Language
中文
Manufacturing
PRODUCTION
CAPABILITIES
Plasmid, virus, and cell production
fully closed system from apheresis to final product infusion
Features
- Single-use customized closed system
- Minimal manipulation
- Rapid genetic modification
- Minimized risk of contamination
Suzhou GMP facility
Shanghai R&D facility
Suzhou GMP facility
Total 63,000 sq.ft standalone manufacturing facility designed by an European company with rich experience in cell gene therapy CMO
Total 21,500 sq.ft GMP clean area: 5 functional areas
Annual production capacity: 12,000 universal samples, and 3,200 autologous FasT CAR samples
Supply for clinical development and early-stage commercialization
Reserved capacity for external partnership programs
5 acres of perspective commercial plant
63,000Sq.ft
standalone manufacturing facility
21,500Sq.ft
GMP clean area
12,000+
Universal samples
3,200+
Autologous FasT CAR samples
Shanghai R&D facility